Will Adial Pharmaceuticals initiate further equity financing before April 2027?
Resolves: Company files for a public offering of common stock or warrants, or enters a definitive equity distribution agreement.
sec_filing· Corporate Finance
Will Adial Pharmaceuticals initiate further equity financing before A…
Market overview
Derived from ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525) 10-Q filing analysis
Corporate Finance prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-04-21
About this prediction
Resolution criteria
Company files for a public offering of common stock or warrants, or enters a definitive equity distribution agreement.
More Corporate Finance markets
- GPI Share Repurchase Announcement — 65% Yes
- TCBX increases share repurchase authorization before 2027 — 65% Yes
- Capital Restructuring Announcement — 60% Yes
- Announcement of non-core asset partnership — 55% Yes
- TCBX completes at least $5M of share repurchases by Q1 2027 — 85% Yes
- Will Integrated Rail & Resources raise over $50M in capital by mid-2027? — 65% Yes
- Will Nuburu secure additional capital financing by Q1 2027? — 65% Yes
- AMAL initiates share repurchases under new program by Q1 2027 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…